Doctor.One secures €4M to expand its asynchronous care model for chronic patients across Europe

The EIT Health supported Doctor.One has raised a €4M seed round led by YZR Capital, with participation from Impact Ventures and existing investors. The funding will support Doctor.One’s expansion into Germany, Spain, and the UK, building on its early commercial success in Poland and surging demand for chronic care solutions that move beyond episodic or telemedicine models.

Poland-based health-tech startup Doctor.One enables continuous, asynchronous care between healthcare professionals and their chronic patients, extending the trusted relationships built during in-person visits. Rather than replacing the physician-patient connection, the platform strengthens it—empowering healthcare professionals to support their patients between hospital appointments or clinic visits without overloading their schedules.

The company is currently running programmes with pharmaceutical companies Novartis, Novo Nordisk, Merck and AstraZeneca, helping its partners improve adherence, patient engagement, and long-term outcomes through structured digital care paths and human touch.

With almost half a million of microinteractions facilitated across therapeutic areas such as obesity, oncology, neurology, and endocrinology, the platform has proven both clinically valuable and psychologically resonant.

“We are strong believers in exceptional teams fixing crucial problems on a large scale with innovative solutions.” said Markus Feuerecker, the Co-Founder and Managing Partner from YZR Capital. “In Doctor.One we found such a team that stands out with their asynchronous care model and already proven success in tackling key issues in care pathways using scalable technology while providing clear value to patients, providers and pharma groups at the same time.”

Operating in full compliance with GDPR and ISO standards, the team is now preparing to scale its platform across Germany, Spain and UK —Europe’s largest healthcare markets.

“We aim to become the go-to digital companion for healthcare professionals managing chronic patients—keeping them connected, informed, and supported between in-person visits”, concludes Maciej Malenda, the co-founder and CEO of Doctor.One.

EIT Health recognised Doctor. One’s potential in 2022, when the team won the NephroHero competition organised by the Warsaw Health Innovation Hub and EIT Health. This success secured a grant to design and test an innovative app for the early diagnosis and treatment of patients with chronic kidney disease (CKD). It also opened a new path for Doctor.One, paving the way for global partnerships with pharmaceutical companies and setting the stage for the company’s latest achievements.